Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+26.4%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$9.23B
AUM Growth
+$1.45B
(+19%)
Cap. Flow
-$211M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
1,206
New
212
Increased
430
Reduced
347
Closed
177
Top Buys
| 1 |
Qualcomm
QCOM
|
+$71.6M |
| 2 |
AutoZone
AZO
|
+$65.5M |
| 3 |
Hershey
HSY
|
+$44.5M |
| 4 |
General Motors
GM
|
+$41.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$41.2M |
Top Sells
| 1 |
Mastercard
MA
|
+$109M |
| 2 |
Biogen
BIIB
|
+$79.5M |
| 3 |
AbbVie
ABBV
|
+$65.8M |
| 4 |
Coca-Cola
KO
|
+$64.3M |
| 5 |
American Homes 4 Rent
AMH
|
+$47.7M |
Sector Composition
| 1 | Technology | 26.04% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 12.53% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
626
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.25M | 0.01% |
180,748
+5,999
| +3% | +$41.4K |
|
627
Regenxbio
RGNX
$479M
| $1.25M | 0.01% |
+33,827
| New | +$1.25M |
|
628
Adaptive Biotechnologies
ADPT
$1.91B
| $1.24M | 0.01% |
+25,698
| New | +$1.24M |
|
629
Federal Realty Investment Trust
FRT
$8.78B
| $1.24M | 0.01% |
14,589
-880
| -6% | -$75K |
|
630
Ryerson Holding
RYI
$736M
| $1.24M | 0.01% |
220,032
+67,655
| +44% | +$381K |
|
|
AJRD
631
DELISTED
Aerojet Rocketdyne Holdings, Inc.
AJRD
| $1.24M | 0.01% |
+31,185
| New | +$1.24M |
|
|
SBBP
632
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.23M | 0.01% |
325,284
+128,636
| +65% | +$486K |
|
633
Park National Corp
PRK
$2.75B
| $1.23M | 0.01% |
17,440
| – | – |
|
|
ZAGG
634
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $1.23M | 0.01% |
390,293
+263,914
| +209% | +$829K |
|
|
RVI
635
DELISTED
Retail Value Inc. Common Shares
RVI
| $1.21M | 0.01% |
1,069,058
+159,919
| +18% | +$181K |
|
636
Protagonist Therapeutics
PTGX
$3.5B
| $1.21M | 0.01% |
68,279
-4,078
| -6% | -$72K |
|
637
Burlington
BURL
$18.3B
| $1.2M | 0.01% |
+6,098
| New | +$1.2M |
|
638
Exelon
EXC
$43.4B
| $1.2M | 0.01% |
46,330
-15,954
| -26% | -$413K |
|
639
Merchants Bancorp
MBIN
$1.51B
| $1.17M | 0.01% |
95,123
+1,295
| +1% | +$16K |
|
640
Chubb
CB
$111B
| $1.17M | 0.01% |
9,242
-5,741
| -38% | -$727K |
|
641
Kiniksa Pharmaceuticals
KNSA
$2.71B
| $1.15M | 0.01% |
45,157
-4,367
| -9% | -$111K |
|
642
Commercial Vehicle Group
CVGI
$67.3M
| $1.14M | 0.01% |
394,466
+5,659
| +1% | +$16.4K |
|
643
Puma Biotechnology
PBYI
$230M
| $1.13M | 0.01% |
108,689
+25,244
| +30% | +$263K |
|
644
Capital City Bank Group
CCBG
$745M
| $1.13M | 0.01% |
54,037
+5,392
| +11% | +$113K |
|
|
ALXN
645
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.13M | 0.01% |
+10,055
| New | +$1.13M |
|
|
CORR
646
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $1.13M | 0.01% |
+123,332
| New | +$1.13M |
|
647
Catalyst Pharmaceutical
CPRX
$2.46B
| $1.13M | 0.01% |
243,650
-4,766
| -2% | -$22K |
|
648
AeroVironment
AVAV
$11.8B
| $1.12M | 0.01% |
+14,095
| New | +$1.12M |
|
649
Seres Therapeutics
MCRB
$200M
| $1.12M | 0.01% |
11,765
+1,146
| +11% | +$109K |
|
650
Manhattan Associates
MANH
$13.3B
| $1.11M | 0.01% |
11,807
-178,691
| -94% | -$16.8M |
|